RobertMFliegelmanDO

PubMed

• 10 citations
  Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2
  Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin, Robert M. Fliegelman, Vishnu Chundi, Vishal Didwania, Alice Han, Brian P. Harting, David W. Hines> ;Critical Care Explorations. 2021 Mar 29
• 8 citations
  A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline.
  Nicholas W. Van Hise, Russell M. Petrak, Nathan C. Skorodin, Robert M. Fliegelman, Michael Anderson, Vishal Didwania, Alice Han, Kairav Shah, Vishnu Chundi, David W. H...> ;Infectious Diseases and Therapy. 2020 Oct 15
• 15 citations
  Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.
  Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise, Robert M. Fliegelman, Jonathan Pinsky, Vishal Didwania, Michael Anderson, Melina Diaz, Kairav Shah, Vishnu...> ;Clinical and Translational Science. 2021 Nov 1
• 28 citations
  Infectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.
  Akshay Shah, Russell M. Petrak, Robert M. Fliegelman, Nabin K. Shrestha, Geneve M. Allison, John Zurlo, Steven Parker, Donald M. Poretz, David S. McKinsey, Mark J. Dou...> ;Clinical Infectious Diseases. 2019 Mar 19
• 20 citations
  Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.
  Russell M. Petrak, Nathan C. Skorodin, Robert M. Fliegelman, David W. Hines, Vishnu Chundi, Brian P. Harting> ;Open Forum Infectious Diseases. 2016 Oct 1
• 19 citations
  Economic impact of oral ciprofloxacin following standard intravenous therapy.
  Robert M. Fliegelman, Patricia M. Mattingly, Cindy L. Dempsey, Stephen J. Sokalski> ;Diagnostic Microbiology and Infectious Disease. 1990 Mar 1
• 3 citations
  An unforeseen complication of home parenteral antibiotic therapy
  James H. Burks, Robert M. Fliegelman, Stephen J. Sokalski> ;Archives of Internal Medicine. 1989 Jul 1
• 6 citations
  The prevalence of hepatitis B serologic markers in suburban paramedics
  Denise J. Fligner, Herbert N. Wigder, Phillip M. Harter, Robert M. Fliegelman, Mark Jewell, Patt Perlman> ;The Journal of Emergency Medicine. 1989 Jan 1
• 11 citations
  Infection following coronary artery surgery. Comparison of two antibiotic prophylaxis regimens
  Mark Jewell, Zev Davis, Robert M. Fliegelman, Joel Guillory, Stephen J. Sokalski> ;Chest. 1988 Apr 1
• 6 citations
  A pseudoepidemic due to Salmonella typhimurium.
  Alan A. Harris, John C. Pottage, Robert M. Fliegelman, Larry J. Goodman, Stuart Levin, Marsha Vetter, R L Kaplan> ;Diagnostic Microbiology and Infectious Disease. 1983 Dec 1
• Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
  Goodman, L. J., Fliegelman, R. M., Trenholme, G. M., Kaplan, R. L.> ;Antimicrob Agents Chemother. 1984 Apr
• Ceftazidime in the therapy of serious Gram-negative bacillary infections.
  Pottage, J. C., Karakusis, P. H., Fliegelman, R. M., Levin, S., Trenholme, G. M.> ;J Antimicrob Chemother. 1983 Jul
• Erysipelothrix rhusiopathiae endocarditis: report of a case and review of the literature.
  Fliegelman, R. M., Cohen, R. S., Zakhireh, B.> ;J Am Osteopath Assoc. 1985 Jan 01
• Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.
  Fliegelman, R. M., Petrak, R. M., Goodman, L. J., Segreti, J., Trenholme, G. M., Kaplan, R. L.> ;Antimicrob Agents Chemother. 1985 Mar 01
• Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets.
  Goodman, L. J., Kaplan, R. L., Petrak, R. M., Fliegelman, R. M., Taff, D., Walton, F., Penner, J. L., Trenholme, G. M.> ;Antimicrob Agents Chemother. 1986 Feb
• Join now to see all